Complement Inhibitors in Clinical Trials for Glomerular Diseases

Defective complement action is a cause of several human glomerular diseases including atypical hemolytic uremic syndrome (aHUS), anti-neutrophil cytoplasmic antibody mediated vasculitis (ANCA), C3 glomerulopathy, IgA nephropathy, immune complex membranoproliferative glomerulonephritis, ischemic repe...

Descripción completa

Detalles Bibliográficos
Autores principales: Zipfel, Peter F., Wiech, Thorsten, Rudnick, Ramona, Afonso, Sara, Person, Fermin, Skerka, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776600/
https://www.ncbi.nlm.nih.gov/pubmed/31611870
http://dx.doi.org/10.3389/fimmu.2019.02166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6776600/
https://www.ncbi.nlm.nih.gov/pubmed/31611870
http://dx.doi.org/10.3389/fimmu.2019.02166

Ejemplares similares